What Is Hypothyroid Myopathy and What Are the Symptoms?

Explore hypothyroid myopathy: the specific muscle disorder caused by low thyroid hormone. Understand the signs, underlying mechanism, and diagnosis.

Hypothyroid myopathy is a disorder of skeletal muscle caused by insufficient thyroid hormone. It shows up as muscle weakness, stiffness, cramps, aching, and easy fatigue, and the majority of people with frank hypothyroidism report at least some of these symptoms. What makes the condition tricky is that muscle problems can sometimes be the only obvious sign of an underactive thyroid, appearing before the more familiar complaints like weight gain, cold intolerance, or sluggishness.

How Thyroid Hormone Affects Muscle

Thyroid hormones regulate how muscle cells produce and use energy. When those hormones drop, several things go wrong at once. The breakdown of glycogen, the stored fuel muscles draw on at the start of exercise, is delayed, limiting the energy supply right when muscles need it most. At the same time, the high-energy phosphate compounds that power rapid contractions become depleted faster and recover more slowly than they should, pointing to impaired mitochondrial function. The net effect is muscle that tires quickly, recovers slowly, and handles acid buildup poorly.

Beyond energy metabolism, the muscle fibers themselves change. Thyroid deficiency causes atrophy and loss of type II fibers, the fast-twitch fibers responsible for quick, powerful movements. As these fibers shrink or disappear, the remaining slow-twitch type I fibers become proportionally dominant. This shift toward slow fibers helps explain why people with hypothyroid myopathy lose explosive strength and feel sluggish during movement, even if their muscles look normal or, paradoxically, appear enlarged. Muscle hypertrophy in hypothyroidism is driven partly by an excessive accumulation of glycosaminoglycans, gel-like substances that swell the tissue from the inside. The combination of altered contractile proteins, disrupted metabolism, glycosaminoglycan deposits, and the replacement of fast fibers by slow ones accounts for much of the clinical picture.

The Core Symptoms

The hallmark complaints of hypothyroid myopathy are stiffness, muscle aches (myalgias), cramps, weakness, and easy fatigability. Stiffness tends to be worst after rest and in cold weather. Cramps are common and can be painful enough to wake you at night. Weakness usually targets the muscles closest to the trunk, so climbing stairs, standing from a chair, or lifting your arms overhead becomes harder before grip strength or fine motor skill is affected.

One classic physical finding is a delayed relaxation phase of deep tendon reflexes, sometimes called the Woltman sign. When a doctor taps your knee or ankle tendon with a reflex hammer, the contraction happens normally, but the muscle takes noticeably longer to relax afterward. This sluggish reflex relaxation directly reflects the slowed muscle metabolism. It is not always dramatic enough to catch in a brief exam, but when present it is a strong clinical clue.

What makes hypothyroid myopathy easy to miss is that these symptoms overlap with dozens of other conditions. Generalized aches and fatigue are among the most common complaints in any primary care office. A person might chalk up the stiffness to aging, the cramps to dehydration, the fatigue to poor sleep. The critical point is that muscle symptoms can be the predominant or even the sole clinical manifestation of hypothyroidism, sometimes appearing before the more recognizable signs of thyroid failure. If unexplained muscle problems are your main complaint, thyroid testing is an important step that sometimes gets overlooked.

Hoffmann’s Syndrome and Kocher-Debré-Semelaigne Syndrome

When hypothyroid myopathy develops alongside visible muscle enlargement, clinicians assign it a more specific name depending on the patient’s age. In adults and adolescents, the combination of muscle hypertrophy, stiffness, weakness, and painful cramps due to long-standing untreated hypothyroidism is called Hoffmann’s syndrome. Despite the bulky appearance, the enlarged muscles do not deliver extra strength; the hypertrophy is pseudohypertrophy, swelling without functional gain.

Case reports illustrate how dramatic this can look. Two adult men with Hoffmann’s syndrome had generalized muscle hypertrophy, extremely high creatine kinase levels, dry skin, and hoarseness. One had progressive lower-limb stiffness for 13 years before diagnosis. After starting thyroid hormone replacement, both showed a remarkable reduction in muscle bulk within two months and were symptom-free at six months. MRI of their lower limbs showed a distinctive pattern involving the posterior and adductor compartments of the thighs and the posterior and lateral compartments of the legs.

In children, the equivalent condition is called Kocher-Debré-Semelaigne syndrome. It presents with muscular pseudohypertrophy in the setting of moderate-to-severe hypothyroidism and is rare. Affected children may have calf muscle enlargement that mimics the appearance of a muscular dystrophy, alongside growth failure and developmental delay. Orofacial features, including enlarged tongue and delayed tooth eruption, may also be present. Both syndromes are reversible with thyroid hormone replacement, which distinguishes them from the genetic muscle diseases they can imitate.

Creatine Kinase and Diagnosis

One of the most useful early clues to hypothyroid myopathy is an elevated serum creatine kinase (CK) level. CK is an enzyme that leaks out of damaged muscle cells into the blood. In overt hypothyroidism, CK is frequently elevated, and there is a positive correlation between CK and TSH levels. Most of the time the elevation is modest, but it can occasionally reach extreme levels, into the tens of thousands, mimicking an inflammatory myopathy or a dystrophy. One reported case showed a CK over 29,000 IU/L in a patient whose subsequent workup revealed profound hypothyroidism as the sole cause.

This matters because an unexplained CK elevation is a common reason people get referred to a rheumatologist or neurologist. If thyroid function is not checked early, the workup can spiral into muscle biopsies and immunosuppressive medications that are unnecessary. Hypothyroid myopathy can be misdiagnosed as immune-mediated necrotizing myopathy if thyroid function tests are not obtained. A case series examining polymyositis-like presentations found that muscle biopsies in hypothyroid patients showed degeneration and atrophy without the necrosis or inflammation typical of true autoimmune muscle disease. A simple TSH and free T4 blood draw can prevent this diagnostic detour entirely.

Electromyography (EMG) and nerve conduction studies can add information but are not always straightforward. In some patients, EMG shows myopathic changes such as short-amplitude, polyphasic motor unit potentials and mild spontaneous activity. However, in a classic series of hypothyroid patients, electromyographic evidence of genuine myopathy was only rarely obtained, while prolonged distal motor latencies, suggesting nerve involvement, were common. This highlights that hypothyroidism can damage both nerve and muscle, and the clinical picture may blend features of both. MRI can help differentiate Hoffmann’s syndrome from inflammatory myopathy or infection by showing the hypertrophic configuration and signal changes of the involved muscles.

When Statins Enter the Picture

Statin cholesterol-lowering drugs are well known for causing muscle aches in some users. When a person taking a statin also has untreated or undertreated hypothyroidism, the two conditions can act together to push muscle damage into dangerous territory. The coexistence of statin therapy and hypothyroid states may synergistically increase the risk of myopathy. This has been documented in patients with naturally occurring hypothyroidism and also in thyroid cancer patients who were deliberately made hypothyroid by stopping levothyroxine before radioiodine treatment while they continued taking statins.

Case reports describe life-threatening rhabdomyolysis, the rapid breakdown of muscle tissue that floods the bloodstream with CK, myoglobin, and potassium, arising from this combination. The practical takeaway is straightforward: if you are on a statin and develop new muscle pain, weakness, or dark urine, thyroid function should be checked alongside CK. And if you know you are hypothyroid, your thyroid levels should be well controlled before starting or continuing a statin.

Rhabdomyolysis and Respiratory Muscle Weakness

Even without statin use, severe hypothyroidism on its own can trigger rhabdomyolysis, especially after vigorous exercise. The risk of rhabdomyolysis in hypothyroidism is greater in patients using statins or after rigorous exercise. In severe cases, the resulting flood of muscle breakdown products can overwhelm the kidneys, triggering acute renal failure. Hypothyroidism itself also reduces kidney blood flow, compounding the problem.

A less recognized complication is weakness of the breathing muscles, including the diaphragm. In a study of hypothyroid patients, diaphragm strength was substantially reduced, and all patients showed a fatiguing breathing pattern. After hormone replacement, diaphragm strength improved markedly, and carbon dioxide levels normalized in those who had been retaining CO₂. A separate case report documented a patient whose primary complaint was breathlessness, caused by severe diaphragm and respiratory muscle weakness due to hypothyroidism. Both diaphragm strength and phrenic nerve conduction times improved with thyroxine treatment. Diaphragmatic dysfunction in hypothyroidism may occur more frequently than has been suspected and can range from mild exercise limitation to overt hypoventilation.

Muscle Symptoms in Subclinical Hypothyroidism

Subclinical hypothyroidism, the stage where TSH is elevated but thyroid hormone levels remain in the normal range, is far more common than overt hypothyroidism. The question of whether it causes real muscle problems has been debated, and the evidence suggests it does, at least for some people. In one study, cramps were reported by roughly 55% of people with subclinical hypothyroidism compared with 25% of controls, and weakness was present in about 45% versus 13%. Women with subclinical hypothyroidism also showed measurably reduced handgrip strength, quadriceps strength, and six-minute walk distance compared with euthyroid controls.

These findings complicate the common clinical decision of whether to treat subclinical hypothyroidism. Guidelines generally recommend treatment only when TSH is clearly elevated or symptoms are present. The muscle data suggest that “symptoms are present” may apply more often than providers assume, especially if they are not specifically asking about cramps, weakness, or exercise tolerance. Impaired muscle energy metabolism has been described in subclinical disease and may improve with levothyroxine.

Treatment and How Quickly Muscles Recover

The good news is that hypothyroid myopathy is fundamentally reversible with thyroid hormone replacement. The less good news is that not everything recovers at the same speed, and some people experience lingering weakness for a long time. In a longitudinal study, CK levels and the sluggish reflex relaxation time normalized relatively quickly, often before TSH had returned to normal. Actual muscle strength, however, was slower to come back. Weakness rarely resolved before TSH normalized, and seven patients in the study remained weak at the end of the observation period despite being euthyroid for an average of one year, although strength did improve modestly overall.

Similarly, the two men with long-standing Hoffmann’s syndrome saw visible reduction in muscle bulk within two months and complete symptom resolution within six months of starting levothyroxine. For respiratory muscle weakness, maximal pressures improved progressively on treatment but still had not reached the normal range after six months in one documented case, even after thyroid levels were normal.

The pattern is consistent across studies: blood markers and reflexes improve first, bulk and stiffness next, and raw strength last. If you have been hypothyroid for a long time, expect that rebuilding strength will take patience, possibly well beyond the point where your labs look normal. Progressive resistance exercise during recovery is reasonable once thyroid levels are stable, though there is no large trial specifically studying exercise protocols in this population.

What Muscle Biopsy Actually Shows

Most people with hypothyroid myopathy never need a muscle biopsy because the diagnosis is made through blood work and the response to thyroid hormone replacement. When biopsies are performed, usually because the clinical picture looks ambiguous, the findings are distinctive. The hallmark is type II fiber atrophy and loss, correlating with clinical and biochemical evidence of myopathy. In some cases, biopsies reveal structural abnormalities within the remaining type I fibers, including “cores” visible on oxidative enzyme staining and, under the electron microscope, disruption of the contractile filaments and absent mitochondria in the affected zones.

An important negative finding is the absence of necrosis or inflammation on biopsy. This is what separates hypothyroid myopathy from inflammatory myopathies like polymyositis and dermatomyositis, where immune cells actively invade and destroy muscle fibers. The distinction matters because treatment for inflammatory myopathies involves immunosuppressive drugs that carry serious side effects and would be entirely unnecessary for a thyroid-related problem. When clinicians encounter a patient with proximal weakness, high CK, and equivocal biopsy findings, simply checking thyroid function before committing to immunosuppression can avoid months of unnecessary and potentially harmful therapy.